News
2h
Money Talks News on MSNYour Red Candy's Days Are Numbered: FDA Phases Out Controversial DyeThe FDA has announced a sweeping ban on Red Dye No. 3, giving food companies three years to reformulate their products.
The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...
Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the ...
9h
Fintel on MSNAscendiant Capital Initiates Coverage of Aytu BioPharma (AYTU) with Buy RecommendationFintel reports that on June 30, 2025, Ascendiant Capital initiated coverage of Aytu BioPharma (NasdaqCM:AYTU) with a Buy ...
Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern Hemisphere Briefing documents submitted to FDA for a Type D meeting ...
Plaintiffs argued the statute would indirectly ban abortion medications by threatening providers with disciplinary action for ...
From cutting the Job Corps to sneaking in scary artificial intelligence regulation, many fear Trump is trying to distract ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna in May voluntarily withdrew an application seeking approval of its combination shot targeting Covid-19 and influenza ... in the U.S., Hoge said Moderna is engaging closely with the FDA to ...
It’s a question laid to rest years ago, as studies showed no evidence that the preservative causes any health problems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results